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Background: Infectious travelers’ diarrhea (TD) is a well-appreciated problem among service members serving
abroad, particularly where infrastructure is limited due to ongoing combat operations, and efforts at sanitation and
hygiene may not be considered an immediate priority. Bacterial and viral causes of travelers’ diarrhea are well-described
among deployed service members, however, gastrointestinal protozoan infections among deployed service members
are less well documented. This study’s purpose was to identify potential risk factors for, and clinical presentations
of, enteric protozoan infections in an active duty military population deployed to combat operations in the
Southwest Asia.
Methods: A cross-sectional study of enteric protozoan infections among US service members deployed in Al-Asad Air
Base, Iraq in support of Operation Iraqi Freedom (OIF) was conducted in summer 2004. Subjects were obtained through
a randomized sector sampling scheme, and through presentations for care at the air base medical facilities. All study
participants provided a stool sample, either diarrhea or solid, upon study entry and completed a questionnaire
documenting demographic information, clinical symptoms of any prior diarrheal episodes, and health risk behaviors.
Basic diagnostic microscopy for protozoa was conducted to include acid-fast and modified trichrome staining.
Results: Four hundred thirty-seven subjects were included in the analysis, and 75 (17.1 %) subjects were found to
have enteric protozoan infections as identified by diagnostic stool microscopy. Blastocystis hominis (n = 36), Entamoeba
coli (n = 25), Endolimax nana (n = 20), and Entamoeba histolytica (n = 5) were the predominant organisms isolated.
Crude incidence of prior episodes of diarrhea was greater among subjects from whom enteric protozoa were isolated
compared to those without (IRR 1.66, 95 % CI 1.47-1.87). Bivariate analysis of health risk and hygiene behaviors found
increased odds for presence of Blastocystis hominis among those service members who reported off base ice (OR 3.61,
95 % CI 1.40-9.28) and raw vegetable consumption (OR 8.18, 95 % CI 1.40-47.5).
Conclusions: This study suggests that US service members deployed to the early stages of OIF were at greater risk of
acquiring enteric protozoa than previously understood. The noted prevalence of enteric protozoa among US service
members in this study is higher than in prior reports, approaching prevalence expected in the general host nation
population, suggesting that US service members operating at Al-Asad Air Base in early OIF were exposed to greater
degrees of fecally contaminated food and water, and poor hygienic and sanitation practices. Consumption of food and
water prepared by host nation parties in Southwest Asia may place US service members at risk for acquiring intestinal
protozoa.* Correspondence: john.downs@mail.us.army.mil
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Infectious diarrhea has remained a problem for service
members serving abroad for centuries, particularly in
those settings where infrastructure is still limited due to
ongoing combat operations, and efforts at sanitation and
hygiene may not be considered an immediate priority
[1]. Outbreaks of gastrointestinal illness were noted to
negatively impact coalition troops during the initial
stages of both Operations Iraqi Freedom (OIF) and En-
during Freedom (OEF) [1, 2]. Seventy-six percent of sol-
diers returning from Iraq or Afghanistan in 2003-2004
reported diarrhea during the deployment with 46 %
reporting a decrease in job performance for an average
of 2 days [3]. As would be expected, reports of stool
samples from service members in the early stages of the
most recent war in Iraq yielded pathogens typically asso-
ciated with infectious diarrhea such as Shigella, entero-
toxigenic E. coli (ETEC), enteroaggregative E. coli
(EAEC), and norovirus. However, descriptions of gastro-
intestinal protozoan infections among deployed service
members are less well documented. This study’s purpose
was to identify potential risk factors for and clinical pre-
sentations of enteric protozoan infections in an active
duty military population deployed to combat operations
in the Southwest Asia, specifically Iraq. This study had
two objectives: (1) to characterize the burden of intes-
tinal protozoan infection within an active duty military
population performing combat operations in Southwest
Asia, and (2) to examine the potential risk factors and
health risk behaviors associated with the observed preva-
lence of intestinal protozoa within this population. An
improved understanding of protozoan associations with
infectious diarrhea may lead to understanding the risk,
optimization of empiric therapy, and identification of
potential methods for prevention.
Methods
Study site
This study was conducted at Al-Asad Airbase, Iraq in
summer 2004. Al-Asad Airbase is an Iraqi Air Force
base located in Al Anbar province of western Iraq. At
the time of this study, the base was home to approxi-
mately 8,000 U.S. service members, predominantly U.S.
Marines from marine expeditionary and aviation units.
A small hospital and several smaller clinics were estab-
lished within fixed facilities on the base. Primary food
service consisted of two large cafeterias which provided
three hot meals per day. The cafeterias were staffed with
a significant number of foreign contractors, which is a
common practice among military contractors. These fa-
cilities were regularly inspected by Navy Preventive
Medicine Unit personnel. Additional host nation food
vendors were available on base at times, but these sources
were not inspected by preventive medicine personnel.Military personnel may have been exposed to off base
sources of food and drink during patrols or engagements
among the Iraqi populace. Bottled water was available for
consumption. Toileting was limited to chemical toilets.
Study population
Individuals were considered eligible for the study if they
were active duty military or a military beneficiary, 18
years or older, had received no antibiotic therapy within
the 72 h prior to enrollment (excluding malaria prophy-
laxis), and had been in Iraq for more than 48 h. Only
those subjects for whom stool microscopy results and
survey data were available were included in the final
analysis.
Enrollment and follow-up
This study was conducted over a three week period in
summer 2004 as part of larger cross-sectional, case find-
ing study that sought to identify cases of infectious diar-
rhea and asymptomatic controls. A total of 552 subjects
were recruited to the study including acute diarrheal
cases presenting for medical care, acute diarrheal cases
not presenting for medical care (identified during a ran-
domized sector convenience sampling scheme encom-
passing non-restricted areas of the airbase), and
asymptomatic participants (similarly located through the
same randomized sector sampling scheme). The random
sector sampling scheme was created by dividing the base
into 12 sectors, sans restricted areas. Investigators ini-
tially randomly selected four sectors a day for three days
(via the use of a multi-sided die) for selection of “cases
not seeking care” and asymptomatic patients. One of
four study teams were sent to each selected sector each
day to recruit and enroll subjects through a convenience
sampling technique. The rotation of sectors for sampling
was continued throughout the study period based on the
original three days randomization. Subjects included in
the final analysis for this study were those subjects iden-
tified in the larger study for which results of stool diag-
nostic studies for protozoa were available. In total, 437
subjects were included for analysis, of which 111 were
symptomatic diarrheal cases at the time of enrollment.
Specimen collection, processing and testing
All study participants provided a blood sample and a
stool sample, either diarrhea or solid, upon study entry
and completed a questionnaire documenting demographic
information, clinical symptoms of any prior diarrheal epi-
sodes, and health risk behaviors. Study questionnaires
were collected at the time of stool sample submission.
Stool specimens and study questionnaires were placed
into a cooler and transported to the laboratory twice each
day. All stool samples underwent microbiologic analysis
for bacterial, viral, and protozoan causes as part of the
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for protozoa was conducted by NAMRU-3 staff to include
acid-fast and modified trichrome staining.
Study definitions
A case of enteric protozoa infection was defined by the
direct visualization on diagnostic stool microscopy of
protozoal cysts or trophozoites from the stool specimen
submitted. This case definition was utilized both for
those subjects with acute diarrhea at the time of enroll-
ment, and for those subjects that were asymptomatic on
enrollment.
Data management
Study stool samples and questionnaires were linked by a
unique identification number (UID) assigned to each
subject. This was done to ensure and maintain the confi-
dentiality of study subjects. The UID was included on all
questionnaires, clinical forms, stool samples, and labora-
tory forms. All data was entered and verified using
Microsoft Access database.
Statistical analysis
Subjects from whom enteric protozoa were identified
were compared to those with no enteric protozoa identi-
fied from stool samples. Due to the frequency in which
it was identified, additional analysis was conducted com-
paring those subjects from whom only Blastocystis homi-
nis was isolated to those subjects with no enteric
protozoa isolated from stool. Univariate analysis was
conducted using standard statistical tests. Comparisons
of median age, median time in theater, and median time
at Al-Asad were conducted with Wilcoxon Rank Sum
tests. Testing of independent categorical variables was
conducted with either Pearson’s chi-square test or Fish-
er’s Exact test. Crude incidence rates of prior episodes of
diarrhea were calculated using the number of self-
reported prior episodes of diarrhea during the deploy-
ment, and the self-reported days in theater. Poisson
regression was used to estimate incidence rates and con-
fidence intervals, and crude incidence rate ratios. Health
risk behavior survey responses in some cases utilized
Likert scales. For analysis, these responses were dichoto-
mized so that responses of “always” or “frequently” were
treated as “yes”, and those responses indicating “rarely”
or “never” were treated as “no.” Likert responses of
“sometimes” were removed from analysis. Unadjusted
odds ratios were obtained through bivariate logistic re-
gression analysis to assess the strength of association be-
tween individual health risk behaviors and the presence
of enteric protozoa. All data analysis was conducted
using Stata/IC Version 12.1, (StataCorp, College Station,
TX) and statistical significance was set at p < 0.05.Ethical compliance
This study (DOD# NAMRU3.2004.0011) was reviewed
and approved by the Institutional Review Board of the
US Naval Medical Research Unit No. 3 in compliance with
all Department of Navy Federal regulations governing the
protection of human subjects. Informed consent was ob-
tained and documented from all adult participants.Results
This study determined there were a total of 437 observa-
tions available for analysis. There were no significant dif-
ferences found by median age, median days in theater, or
median days at Al-Asad Airbase when comparing sub-
jects with enteric protozoa to those without protozoa
isolated (Table 1). No differences in distribution by mili-
tary rank, race, or branch of service were found. Overall,
the subjects were found to have a median age of 23
years, and had approximately 4 months in theater (me-
dian = 126 days) as well as at Al-Asad (median = 112
days). As expected, the overwhelming majority of sub-
jects were enlisted (96.5 %), male (97.7 %), and members
of the United States Marines Corps (86 %).
Enteric protozoa were isolated from 75 (17.1 %) stool
samples. Blastocystis hominis (n = 36), Entamoeba coli
(n = 25), and Endolimax nana (n = 20), made up 90 % of
all identified protozoa with multi- protozoan co-
infections included (Table 2). Fourteen subjects were
found to have multi- protozoan co-infections (Table 3).
No helminths were identified from any stool samples. It
is important to note here that the majority of identified
protozoa were non-pathogenic organisms, although the
pathogenicity of Blastocystis hominis remains controver-
sial even at present. Only six subjects were identified to
have true infections with enteric protozoa widely consid-
ered to be pathogenic, Entamoeba histolytica (n = 5) and
Giardia lamblia (n = 1).
Analysis of associated symptoms and health risk be-
haviors at the time of study enrollment found a trend to-
ward greater reported prevalence of current diarrhea
among those without protozoa identified (27.1 %) com-
pared to those subjects with protozoa identified (17.3 %;
p = 0.08). There were no differences noted in prevalence
of reported current fever. Among those who reported
diarrhea previously during the deployment, there were
no significant differences in median number of prior epi-
sodes (3), and no significant differences in diarrhea asso-
ciated symptoms. A near significant (p = 0.07) greater
proportion of subjects with protozoa identified reported
having previous episodes of diarrhea of such severity
that back-up personnel were required to come in to
cover the subject’s work shift. Additionally, near signifi-
cant differences were noted in reporting off base travel
in the prior 5 days. Subjects without protozoa identified
Table 1 Demographics of Study Population
Protozoa Found No Protozoa Found Total p value
n = 75 n = 362 n = 437
Male, n (%) 74 (98.6) 353 (98.0) 427 0.72
Median Days at Al Asad (IQR) 112 (93-118) 112 (101-120) 113 (101-121) 0.44
Median Days in Theater (IQR) 126 (115-130) 126 (117-130) 127 (120-132) 0.89
Median Age (IQR) 23.0 (21-27) 23.0 (21-27) 23.0 (21-27) 0.95
Age, n (%)
<20 4 (5.3) 30 (8.3) 34 (7.8)
20-29 57 (76) 258 (71.2) 315 (72.0)
30-39 10 (13.3) 56 (15.4) 66 (15.1)
40-49 4 (5.3) 16 (4.4) 20 (4.5)
>50 0 (0) 2 (0.5) 2 (0.5) 0.81
Rank, n (%)
E1-E3 36 (48.0) 159 (44.1) 195 (44.8)
E4-E9 36 (48.0) 189 (52.5) 225 (51.7)
Officers 2 (2.7) 11 (3.0) 13 (3.0)
Civilian 1 (1.3) 1 (0.2) 2 (0.5) 0.58
Race, n (%)
African American 3 (4.1) 29 (8.2) 32 (7.5)
Caucasian 52 (71.2) 212 (60.5) 264 (62.4)
Hispanic 15 (20.5) 76 (21.7) 91 (21.5)
Other 3 (4.1) 33 (9.4) 36 (8.5) 0.21
Service, n (%) Marines 67 (89.3) 309 (85.3) 376 (86.0)
Navy 8 (10.7) 48 (13.2) 56 (12.8)
Army 0 (0) 5 (1.4) 5 (1.1)
Active Component, n (%) 67 (89.3) 332 (91.7) 399 (91.3) 0.23
Malaria Prophylaxis, n (%) 66 (88.0) 305 (84.9) 317 (85.5) 0.86
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last 5 days (p = 0.06) (Table 4).
Bivariate analysis suggested that those who reported
having drinks with ice or eating raw vegetables with
meals while off base were at increased odds of having
protozoa identified in their stool samples, although re-
sults were not significant (Table 5). Point estimatesTable 2 Distribution of Enteric Protozoa
Protozoa Distribution n (%)
Blastocystis hominis 27 (36)
Entamoeba coli 19 (25.3)
Endolimax nana 12 (16)
Entamoeba histolytica 1 (1.3)
Iodamoeba butschlii 1 (1.3)
Giardia lamblia 1 (1.3)
Multi protozoa infections 14 (18.7)
Total 75suggest that protozoa-positive subjects were at over 3.5
times greater odds of reporting that they ate raw vegeta-
bles off base (OR 3.70 95 % CI 0.79-3.71). No other sig-
nificant associations were noted between reported health
risk behaviors and subjects with protozoa identified in
stool. When crude incidence rates were calculated,Table 3 - Multi-protozoa Coinfections
n
Blastocystis hominis Chilomastix mesnili 1
Blastocystis hominis Endolimax nana 3
Blastocystis hominis Entamoeba coli 4
Blastocystis hominis Entamoeba histolytica Endolimax nana 1
Endolimax nana Chilomastix mesnili 1
Endolimax nana Entamoeba coli 1
Endolimax nana Entamoeba histolytica 2
Entamoeba histolytica Entamoeba coli 1
Total 14
Table 4 Characteristics of prior diarrhea during deployment
Protozoa Found No Protozoa Found Total p value
Had diarrhea at study enrollment, n (%) 13 (17.3) 98 (27.1) 111 (25.4) 0.08
Fever present at study enrollment, n (%) 1 (1.3) 4 (1.1) 5 (1.1) 0.87
Had other diarrhea episodes during the same deployment 52 (69.3) 230 (63.5) 282 (64.5) 0.34
For Any previous diarrheal episode:
Median # of loose stools/day for any episode (IQR) 4 (3-6) 5 (3-7) 5 (4-7) 0.48
Abdominal Cramps 34 (65.4) 169 (73.4) 203 (72.0) 0.24
Nausea 24 (46.1) 101 (44.3) 125 (44.6) 0.81
Vomiting 6 (11.8) 38 (16.7) 44 (15.7) 0.38
Headache 24 (46.1) 102 (44.5) 126 (44.8) 0.83
Muscle Aches 18 (34.6) 72 (31.5) 90 (32.1) 0.67
Fevers 11 (21.1) 32 (14.1) 43 (15.4) 0.20
Blood in Stool 5 (9.6) 17 (7.4) 22 (7.8) 0.60
Visited Sick Call 16 (30.1) 46 (20.3) 62 (22.2) 0.12
Hospitalized? 1 (1.9) 4 (1.8) 5 (1.8) 0.96
Back Up Called 5 (9.6) 8 (3.5) 13 (4.6) 0.07
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3.31-4.78) prior episodes of diarrhea per 100 person-days
in theater, compared to a rate of 2.39 (95 % CI 2.25-2.55)
per 100 person-days among protozoa-negative subjects.
This resulted in a crude incidence rate ratio of 1.66 (95 %
CI 1.47-1.87), indicating that protozoa-positive subjects
developed prior episodes of diarrhea at a rate 66 % higher
than protozoa-negative subjects in the days after arrival to
theater, but prior to study enrollment.
Of the 75 subjects from which protozoa were identi-
fied, Blastocystis hominis was the only protozoa identi-
fied in the stool samples of 27 subjects (Table 2).
Twenty-one of these 27 subjects (77.8 %) denied having
diarrhea at the time of study enrollment, and only 1 (3.7
%) reported current fever at the time of study enroll-
ment (Table 6). Fifteen of the 27 subjects with Blastocys-
tis hominis only identified reported diarrhea during the
present deployment, and answered survey questions re-
lated to these prior episodes. Among the 15 subjects
with only Blastocystis hominis identified who reported
diarrhea during the present deployment, associated
symptoms included nausea in ten (67 %), abdominal
cramps in nine (60 %), headache in nine (60 %), fever in
five (33 %), blood in stool in two (13.3 %), and vomiting
in one (6.7 %). These proportions are not significantly
different from those seen in subjects without protozoa
identified. However, a greater proportion of subjects
with Blastocystis hominis reported needing to have a
backup called to cover their shift due to gastrointestinal
upset compared to those subjects without protozoa iden-
tified (20 % vs 3.5 %; p = 0.02).
Bivariate analysis (Table 7) comparing subjects with
only Blastocystis hominis identified to those subjectswithout protozoa identified found that subjects with
Blastocystis hominis were at about 70 % lesser odds of
reporting diarrhea on a prior deployment (OR 0.30, 95 %
CI 0.10-0.90). Twenty-three (85 %) of 27 subjects with
Blastocystis hominis only identified denied having had
diarrhea on prior deployments. Point estimates also sug-
gested a trend toward lesser odds of having traveled off
base in the last 5 days for those subjects with Blastocys-
tis hominis only identified (OR 0.16, 95 % CI 0.02-1.27).
Most notably, subjects with Blastocystis hominis only
identified reported over three times greater odds of
using ice in drinks off base (OR 3.61, 95 % CI 1.40-9.28),
and over eight times greater odds of having eaten raw
vegetables off base (OR 8.18, 95 % CI 1.40-47.5).
Discussion
Multiple prior reports have addressed the impact of in-
fectious diarrhea on combat operations during Oper-
ation Iraqi Freedom (OIF). However, limited references
have been made to identified enteric protozoa during ei-
ther OIF or the prior war in Iraq. Thornton et al.’s re-
port on gastroenteritis in U.S. Marines during the initial
invasion of Iraq mentions only a single case of diarrhea
of protozoan etiology (Cryptosporidium) in 129 stool
samples obtained within southern Iraq [2]. However,
Thornton’s study was conducted in the weeks just after
the initial invasion period in spring 2003. Thus, subjects
had been in Iraq for a shorter duration than in our
study, and had been consuming primarily U.S. rations.
In contrast, Monteville et al.’s analysis of service mem-
bers arriving in Qatar for “rest and relaxation” leave
from Iraq or Afghanistan in 2006 found enteric protozoa
in as many as 20 % of those service members with
Table 5 Bivariate Analysis for Risk Factors for Stool Protozoa
Detection






















Diarrhea on prior deployment
No 1.00
Yes 0.83 0.49-1.40
Diarrhea previously on this deployment
No 1.00
Yes 1.30 0.76-2.21
Off Base Travel Last 5 Days
No 1.00
Yes 0.48 0.22-1.03
Ate Off Base Last 5 Days
No 1.00
Yes 0.68 0.27-1.71
Ate On Base Local Last 5 Days
No 1.00
Yes 1.07 0.57-1.98
When eating off base, I have drinks with ice.
No 1.00
Yes 1.71 0.79-3.71




I eat off base




I wash my hands before eating
No 1.00
Yes 1.01 0.11-8.81
I wash my hands after using the latrine
No 1.00
Yes 1.35 0.29-6.15
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16 % of subjects arriving from OIF, most commonly
Blastocystis hominis, Entamoeba coli, and Endolimax
nana. The Monteville et al. study did include members
with longer deployments which may have contributed to
the greater prevalence of intestinal protozoa. This sug-
gested perhaps a greater role of gastrointestinal protozoa
in diarrhea among deployed service members than pre-
viously considered, particularly on extended deploy-
ments. Historically, Hyams and colleagues collected over
400 stool samples from service members with gastro-
enteritis during deployment to Saudi Arabia in prepar-
ation for the First Gulf War with Iraq. Their analysis of
these samples found a bacterial pathogen in about half
of all submitted samples, but found no evidence of intes-
tinal protozoa in any of the over 400 samples [5]. Mal-
one reported in 1991 on a separate sample of over 400
stool samples obtained from U.S. Marines returning for
Operation Desert Shield/Desert Storm, and found Giar-
dia cysts in only 9 specimens with no evidence of other
intestinal protozoa [6]. Of note, subjects in Malone’s
study had apparently entered Iraq as part of combat op-
erations during Operation Desert Storm, but subjects in
Hyams’ study only served in Saudi Arabia for Operation
Desert Shield. All of the above studies appear to have
used similar diagnostic microscopy techniques for iden-
tification of enteric parasitic (protozoa and helminths).
Looking at deployments to the Middle East outside
the Iraq theater, a 1991 report on almost 200 stool sam-
ples collected from service members with acute diarrhea
during a deployment to Egypt also did not find evidence
of intestinal protozoa in these samples [7]. A study con-
ducted in 2002 at a U.S. base in Turkey found intestinal
protozoa in about 4 % of cases of acute travelers’ diar-
rhea [8]. Finding few intestinal protozoa in samples col-
lected for acute diarrheal episodes may be expected as
enteric protozoa are less frequent causes of acute diar-
rhea, but have traditionally been more associated with
chronic or persistent diarrhea [9]. A 2011 study did re-
port a 23% prevalence of protozoa among 72 stool sam-
ples collected from a peacekeeping force in the Sinai
Table 6 Characteristics of Blastocystis sp. Diarrhea
Blastocystis Only Isolated n (27) No Protozoa Isolated n (362) p value
Diarrhea at study enrollment, n(%)
Yes 6 (22.2) 98 (27.1)
No 21 (77.8) 263 (72.9) 0.58
Fever at study enrollment, n(%)
Yes 1 (3.7) 4 (1.1)
No 26 (96.3) 356 (98.9) 0.25
Diarrhea on Prior Deployments
Yes 4 (14.8) 131 (36.3)
No 23 (85.1) 230 (63.7) 0.03
Had other diarrhea episodes during this deployment
Yes 15 (55.6) 230 (63.5)
No 12 (44.4) 132 (36.4) 0.41
Date of last diarrhea
Less than 1 week ago 4 (25) 60 (26.4)
1-2 weeks ago 7 (43.8) 65 (28.6)
3-4 weeks ago 3 (18.8) 46 (20.2)
>4 weeks ago 1 (6.2) 56 (24.7) 0.05
Characteristics of prior diarrhea episodes during this deployment
Abdominal Cramps
Yes 9 (60) 169 (73.5)
No 6 (40) 61 (26.5) 0.25
Nausea
Yes 10 (66.7) 101 (44.3)
No 5 (33.3) 127 (55.7) 0.09
Vomiting
Yes 1 (6.7) 38 (16.7)
No 14 (93.3) 190 (83.3) 0.30
Headache
Yes 9 (60) 102 (44.5)
No 6 (40) 127 (55.50) 0.24
Muscle Aches
Yes 6 (40) 72 (31.6)
No 9 (60) 156 (68.4) 0.50
Joint Pain
Yes 3 (20) 44 (19.4)
No 12 (80) 183 (80.6) 0.95
Fevers 5 (33.3) 32 (14.1)
Yes 10 (66.7) 195 (85.9) 0.06
No
Blood in Stool
Yes 2 (13.3) 17 (7.5)
No 13 (86.7) 211 (92.5) 0.41
Visited Sick Call
Yes 3 (18.8) 46 (20.4)
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Table 6 Characteristics of Blastocystis sp. Diarrhea (Continued)
No 13 (81.2) 180 (79.7) 0.88
Admitted?
Yes 1 (6.2) 4 (1.8)
No 15 (93.8) 221 (98.2) 0.23
Back Up Called
Yes 3 (20) 8 (3.5)
No 12 (80) 221 (96.5) 0.02
Off Base Travel Last 5 Days
Yes 1 (6.7) 70 (30.4)
No 14 (93.3) 160 (69.6) 0.07
Ate Off Base Last 5 Days
Yes 2 (13.3) 37 (16.1)
No 13 (86.7) 193 (83.9) 0.78
Ate On Base Local Last 5 Days
Yes 6 (40) 85 (37.0)
No 9 (60) 145 (63.0) 0.81
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forces in Egypt also reported Blastocystis hominis, Ent-
amoeba coli, and Endolimax nana as the most commonly
identified enteric protozoa. This study also appears to
confirm that the most frequently isolated protozoa among
US service members deployed to the Middle East are Blas-
tocystis hominis, Entamoeba coli, and Endolimax nana as
similarly noted in two prior studies [4, 10]. It is worth-
while to reinforce here that of almost all identified proto-
zoa in this study are non-pathogenic organisms, such as
Entamoeba coli, and Endolimax nana. The pathogenicity
of Blastocystis hominis remains controversial up to the
present, and would have been considered a commensal at
the time of the study [11].
The prevalence of enteric protozoa in this study is
high and suggests that sanitary conditions for US service
members at the time of this study were less than opti-
mal. The reported compliance with appropriate hygiene
measures of washing hands before eating was quite high
(98.4 % of all subjects answered ‘yes’), as well as washing
hands after toileting (95.9 % of all subjects answered
‘yes’), although, these types of questions may introduce a
bias, (e.g., social desirability bias), and compliance with
these and other proper hygiene practices may well have
been much lower. The consumption of off base ice
which presumably would have been provided in an off
base restaurant or a setting where prepared food was
provided indeed had the greatest associations with the
presence of Blastocystis hominis in stool.
This significant proportion of Blastocystis hominis in-
fection (7.5 % of all subjects) in US service members has
not been previously reported. Results in this study would
at least suggest a greater than expected prevalence ofBlastocystis hominis among a group of generally healthy
deployed US service members. Those subjects with only
Blastocystis hominis identified in their stool did not re-
port significant differences in gastrointestinal symptoms
compared to those subjects with no enteric protozoa
identified. However, the small number of Blastocystis
hominis cases that reported associated symptoms of
prior diarrhea (only 15 of 27 answered survey questions
regarding prior episodes of diarrhea) limits the ability to
detect any real differences. Significant controversy re-
mains in the current literature as to the true pathogen-
icity of Blastocystis hominis, and the need to treat when
the organism is identified in stool [11–13]. While gastro-
intestinal symptoms for subjects with Blastocystis homi-
nis infection did not differ significantly from those
subjects without enteric protozoa, the finding that sub-
jects with only Blastocystis hominis isolated more fre-
quently reported having had a back-up called to cover
their shift suggests that whatever symptoms were present
were possibly more severe among those with Blastocystis
hominis. This may be another indication of the potential
pathogenicity of Blastocystis hominis, at least among ser-
vice members who were presumed to have acquired the
protozoa upon arrival into theater. More likely, however,
is that the presence of Blastocystis hominis among those
requesting back-up may simply be indicative of a prior in-
gestion of food or drink with heavy fecal and multi-
pathogen contamination, to include viral and bacterial
causes of acute diarrhea.
The finding of a trend toward a greater proportion of
subjects with protozoa identified reporting no off base
travel in the prior five days may be the result of gastro-
intestinal infection or illness acquired during previous
Table 7 Bivariate Analysis for Risk Factors for Blastocystis sp.
Detection
















Diarrhea on prior deployment
No 1.00
Yes 0.30 0.10-0.90
Diarrhea previously on this deployment
No 1.00
Yes 0.71 0.32-1.57
Date of last diarrhea
Less than 1 week ago 1.00
1-2 weeks ago 1.61 0.45-5.79
3-4 weeks ago 0.97 0.20-4.59
>4 weeks ago 0.27 0.03-2.47
Off Base Travel Last 5 Days
No 1.00
Yes 0.16 0.02-1.27
Ate Off Base Last 5 Days
No 1.00
Yes 0.8 0.17-3.70
Ate On Base Local Last 5 Days
No 1.00
Yes 1.13 0.39-3.30
I have drinks with ice off base.
No 1.00
Yes 3.61 1.40-9.28




I eat off base
No 1.00
Yes 1.56 0.34-7.20
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nesses prevented service members from participating in
off base operations in the days immediately prior to
study entry. The finding of greater incidence of episodes
of diarrhea among those subjects with protozoa identi-
fied suggests that those subjects may have had ongoing
or recurrent episodes of diarrhea rather than acute epi-
sodes which subsequently resolved as may be expected
with an acute bacterial diarrheal infection. Again, these
recurrent episodes may have contributed to service
members having remained on base in the five days prior
to study entry. This may be further evidenced by the
finding of a trend toward greater odds of having re-
quired a back-up to be called in to cover a service mem-
ber’s shift among those with protozoa identified.
This study has a number of notable limitations. It is a
cross-sectional study and therefore subject to the limita-
tions of all cross-sectional studies. Most notably, we are
unable to clearly establish a causal association between
reported health risk behaviors and presence of enteric
protozoa as all information was collected simultaneously.
We have limited information regarding where study sub-
jects may have traveled while en route to Iraq, or how long
they may have remained at those locations. Some service
members did report prior deployments to a variety of lo-
cations, and it is likely that some service members may
have been on shipboard deployments with en route ports
of call prior to their arrival in Iraq. We are unable to de-
termine which, if any, subjects may have arrived to theater
already carrying enteric protozoa, though this is unlikely.
We are confident in our ability to discern Entamoeba coli,
Endolimax nana, and Entamoeba histolytica by diagnostic
microscopy, but recognize that some may note the possi-
bility of misidentifying one species for another. Regardless
of this possibility for misidentification, the presence of any
of these organisms would indicate fecal contamination of
food and/or water sources, and may indicate risk for other
pathogenic enteric protozoa. For this study, we were not
able to consider the possibility of bacterial or viral co-
pathogens that may have contributed to the clinical pres-
entation of study participants. Furthermore, this study is
not a comprehensive assessment for enteric protozoa as
only direct microscopy was used for identification. More
sensitive protozoan identification methods are now avail-
able and FDA-approved, such as enzyme immunoassays
for Entamoeba histolytica and Giardia, and polymerase
chain reaction for Cryptosporidium and Giardia [14]. This
study population was also almost entirely male enlisted
U.S. Marines; thus, any potential gender specific differ-
ences in protozoa presence or risk factors for protozoa
presence were unable to be explored in this study.
This study also has several strengths. To our know-
ledge, this is the only study to date specifically exploring
the prevalence of enteric protozoa among service members
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Iraqi Freedom. The prior reports that have included proto-
zoa etiologies of acute diarrhea among service members
deployed to Southwest Asia have not attempted to link
diarrheal associated symptoms with enteric protozoa pres-
ence. Our study was able to combine information on
health risk behaviors, associated clinical symptoms, and
stool diagnostic microscopy. Additionally, unlike any prior
study among deployed US service members, this study was
also able to associate health risk behavior information with
stool samples positive for Blastocystis hominis. Our results
suggest that the presence of Blastocystis hominis is associ-
ated with greater lost work days, but we are unable to con-
clude at this time whether these lost work days are
attributable to Blastocystis hominis directly, or if its pres-
ence is simply indicative of exposure to a heavy, and poten-
tially diverse, pathogen load previously.
Conclusions
This is the only study to date that attempts to determine
health risk behavior associations specifically with the
presence of enteric protozoa among deployed US service
members. This study found strong associations with
Blastocystis hominis presence in stool samples and prior
reported use of ice in off base drinks, and consumption
of raw vegetables when eating off base during the de-
ployment. Similar, but not statistically significant, results
were noted when all protozoa were pooled for analysis.
This study reiterates the need for deployed US service
members to consume food and water only from sources
that have been approved by US preventive medicine and
public health officials. Consumption of food and water
prepared by host nation parties will likely place US ser-
vice members at risk for acquiring intestinal protozoa.
The noted prevalence of enteric protozoa among US ser-
vice members in this study is higher than in prior re-
ports, approaching prevalence expected in the general
host nation population, which suggests that US service
members operating at Al-Asad Air Base in early stages
of Operation Iraqi Freedom were exposed to greater de-
grees of fecally contaminated food and water, and poor
hygienic and sanitation practices. Future studies should
consider the impact that intestinal protozoa have on unit
readiness, and the clinical effects of Blastocystis hominis
infections on deployed US service members. Study sub-
jects were not followed beyond the study window; there-
fore, we are unable to comment on the potential long
term gastrointestinal consequences of these protozoan
exposures. Future work should also consider the possi-
bility of extended alteration of gut flora following expos-
ure to enteric protozoa.
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